Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000062

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 15, 2017
Accepted (ET)
May 18, 2017 · 10:48 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 15, 2017P1,000$0.06A20,757,949D
Common StockMay 15, 2017P1,000$0.06A20,758,949D
Common StockMay 15, 2017P1,000$0.06A20,759,949D
Common StockMay 15, 2017P1,000$0.06A20,760,949D
Common StockMay 15, 2017P1,000$0.06A20,761,949D
Common StockMay 15, 2017P1,000$0.0599A20,762,949D
Common StockMay 15, 2017P1,000$0.06A20,763,949D
Common StockMay 15, 2017P1,000$0.0606A20,764,949D
Common StockMay 15, 2017P1,000$0.061A20,765,949D
Common StockMay 15, 2017P1,000$0.061A20,766,949D
Common StockMay 15, 2017P1,000$0.0606A20,767,949D
Common StockMay 15, 2017P1,000$0.061A20,768,949D
Common StockMay 15, 2017P1,000$0.061A20,769,949D
Common StockMay 15, 2017P1,000$0.06A20,770,949D
Common StockMay 15, 2017P1,000$0.06A20,771,949D
Common StockMay 15, 2017P1,000$0.06A20,772,949D
Common StockMay 15, 2017P1,000$0.06A20,773,949D
Common StockMay 15, 2017P1,000$0.06A20,774,949D
Common StockMay 15, 2017P1,000$0.06A20,775,949D
Common StockMay 15, 2017P1,000$0.06A20,776,949D
Common StockMay 15, 2017P1,000$0.06A20,777,949D
Common StockMay 15, 2017P1,000$0.06A20,778,949D
Common StockMay 15, 2017P1,000$0.06A20,779,949D
Common StockMay 15, 2017P1,000$0.058A20,780,949D
Common StockMay 15, 2017P1,000$0.0596A20,781,949D
Common StockMay 15, 2017P1,000$0.0596A20,782,949D
Common StockMay 16, 2017P1,000$0.064A20,783,949D
Common StockMay 16, 2017P1,000$0.0639A20,784,949D
Common StockMay 16, 2017P1,000$0.0639A20,785,949D
Common StockMay 16, 2017P1,000$0.0635A20,786,949D

Table II — derivative securities

No Table II lines on this filing.